TreeWAS – Variant ID: rs7014900

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K82.4 Cholesterolosis of gallbladder	0.061	0.939	0.000
K82 Other diseases of gallbladder	0.042	0.958	0.000
K82.1 Hydrops of gallbladder	0.036	0.964	0.000
K82.3 Fistula of gallbladder	0.034	0.966	0.000
K82.0 Obstruction of gallbladder	0.032	0.967	0.000
K82.9 Disease of gallbladder, unspecified	0.032	0.968	0.000
K82.8 Other specified diseases of gallbladder	0.032	0.968	0.000
K82.2 Perforation of gallbladder	0.024	0.976	0.000
Y84.8 Other medical procedures	0.012	0.988	0.000
Y40 Systemic antibiotics	0.010	0.990	0.000
Y40.0 Penicillins	0.010	0.990	0.000
Y54.3 Benzothiadiazine derivatives	0.010	0.990	0.000
Y40.9 Systemic antibiotic, unspecified	0.009	0.991	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.009	0.991	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.009	0.991	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.008	0.992	0.000
Y40.7 Antifungal antibiotics, systemically used	0.008	0.992	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.008	0.992	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.008	0.992	0.000
Y40.6 Rifamycins	0.008	0.992	0.000
Y45.1 Salicylates	0.008	0.992	0.000
Y54.5 Other diuretics	0.008	0.992	0.000
Y45.8 Other analgesics and antipyretics	0.008	0.992	0.000
Y40.3 Macrolides	0.008	0.992	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.008	0.992	0.000
Y46.4 Iminostilbenes	0.007	0.992	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.007	0.993	0.000
Y40.5 Aminoglycosides	0.007	0.993	0.000
Y40.4 Tetracyclines	0.007	0.993	0.000
Y40.2 Chloramphenicol group	0.007	0.993	0.000
Y54.8 Agents affecting uric acid metabolism	0.007	0.993	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.007	0.993	0.000
H18.9 Disorder of cornea, unspecified	0.007	0.993	0.000
Y46.6 Other and unspecified antiepileptics	0.007	0.993	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.007	0.993	0.000
Y58 Bacterial vaccines	0.007	0.993	0.000
Y54.9 Mineral salts, not elsewhere classified	0.007	0.993	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.007	0.993	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.007	0.993	0.000
Y54.0 Mineralocorticoids	0.007	0.993	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.007	0.993	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.007	0.993	0.000
Y54.7 Agents affecting calcification	0.007	0.993	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.007	0.993	0.000
Y54.4 Loop [high-ceiling] diuretics	0.007	0.993	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.007	0.993	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.006	0.994	0.000
Y59 Other and unspecified vaccines and biological substances	0.006	0.994	0.000
Y45.4 Antirheumatics	0.006	0.994	0.000
Y53.4 Other laxatives	0.006	0.994	0.000
Y48 Anaesthetics and therapeutic gases	0.006	0.994	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.006	0.994	0.000
Y41.0 Sulphonamides	0.006	0.994	0.000
Y46.8 Antispasticity drugs	0.006	0.994	0.000
Y46.7 Anti-Parkinsonism drugs	0.006	0.994	0.000
Y46.5 Valproic acid	0.006	0.994	0.000
Y46.3 Deoxybarbiturates	0.006	0.994	0.000
Y46.1 Oxazolidinediones	0.006	0.994	0.000
Y46.0 Succinimides	0.006	0.994	0.000
Y55.4 Expectorants	0.006	0.994	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.006	0.994	0.000
Y58.0 BCG vaccine	0.006	0.994	0.000
Y46.2 Hydantoin derivatives	0.006	0.994	0.000
H18 Other disorders of cornea	0.006	0.994	0.000
Z99.1 Dependence on respirator	0.006	0.994	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.006	0.994	0.000
Y55.5 Anticommon cold drugs	0.006	0.994	0.000
Y55.3 Antitussives	0.006	0.994	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.006	0.994	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.006	0.994	0.000
Y55.0 Oxytocic drugs	0.006	0.994	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.005	0.994	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.005	0.994	0.000
Y41.5 Antiviral drugs	0.005	0.994	0.000
Y41.4 Anthelminthics	0.005	0.994	0.000
Y41.3 Other antiprotozoal drugs	0.005	0.994	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.005	0.994	0.000
Y41.1 Antimycobacterial drugs	0.005	0.994	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.005	0.994	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.005	0.994	0.000
H18.5 Hereditary corneal dystrophies	0.006	0.994	0.000
Y45.2 Propionic acid derivatives	0.005	0.994	0.000
Z99.2 Dependence on renal dialysis	0.005	0.995	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.005	0.995	0.000
Y53.7 Emetics	0.005	0.995	0.000
Y53.6 Antidiarrhoeal drugs	0.005	0.995	0.000
Y53.5 Digestants	0.005	0.995	0.000
Y53.3 Saline and osmotic laxatives	0.005	0.995	0.000
Y53.2 Stimulant laxatives	0.005	0.995	0.000
Y53.0 Histamine H2-receptor antagonists	0.005	0.995	0.000
S20.8 Superficial injuries of other and unspecified parts of thorax	0.000	0.995	0.005
Y49.0 Tricyclic and tetracyclic antidepressants	0.005	0.995	0.000
Z99 Dependence on enabling machines and devices, not elsewhere classified	0.005	0.995	0.000
Y45.5 4-Aminophenol derivatives	0.005	0.995	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.005	0.995	0.000
M47.87 Other spondylosis (Lumbosacral region)	0.005	0.995	0.000
Z99.8 Dependence on other enabling machines and devices	0.005	0.995	0.000
Y58.9 Other and unspecified bacterial vaccines	0.005	0.995	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.005	0.995	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.005	0.995	0.000
Y58.5 Diphtheria vaccine	0.005	0.995	0.000
Y58.4 Tetanus vaccine	0.005	0.995	0.000
Y58.3 Plague vaccine	0.005	0.995	0.000
Y58.2 Cholera vaccine	0.005	0.995	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.005	0.995	0.000
Y49.2 Other and unspecified antidepressants	0.005	0.995	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.005	0.995	0.000
Y40.8 Other systemic antibiotics	0.005	0.995	0.000
K90.0 Coeliac disease	0.005	0.995	0.000
Y56.9 Topical agent, unspecified	0.005	0.995	0.000
Y56.8 Other topical agents	0.005	0.995	0.000
Y56.7 Dental drugs, topically applied	0.005	0.995	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.005	0.995	0.000
Y56.5 Ophthalmological drugs and preparations	0.005	0.995	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.005	0.995	0.000
Y56.3 Emollients, demulcents and protectants	0.005	0.995	0.000
Y56.2 Local astringents and local detergents	0.005	0.995	0.000
Y56.1 Antipruritics	0.005	0.995	0.000
H92.0 Otalgia	0.005	0.995	0.000
Y49.9 Psychotropic drug, unspecified	0.005	0.995	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.005	0.995	0.000
Y49.7 Psychostimulants with abuse potential	0.005	0.995	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.005	0.995	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.005	0.995	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.005	0.995	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.005	0.995	0.000
Y57 Other and unspecified drugs and medicaments	0.005	0.995	0.000
H18.6 Keratoconus	0.005	0.995	0.000
Y49.5 Other antipsychotics and neuroleptics	0.005	0.995	0.000
Y44 Agents primarily affecting blood constituents	0.005	0.995	0.000
Y50.9 Central nervous system stimulant, unspecified	0.005	0.995	0.000
Y50.8 Other central nervous system stimulants	0.005	0.995	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.005	0.995	0.000
Y50.1 Opioid receptor antagonists	0.005	0.995	0.000
Y50.0 Analeptics	0.005	0.995	0.000
Y59.9 Vaccine or biological substance, unspecified	0.005	0.995	0.000
Y59.8 Other specified vaccines and biological substances	0.005	0.995	0.000
Y59.2 Protozoal vaccines	0.005	0.995	0.000
Y59.1 Rickettsial vaccines	0.005	0.995	0.000
Y59.0 Viral vaccines	0.005	0.995	0.000
Y48.2 Other and unspecified general anaesthetics	0.005	0.995	0.000
Y59.3 Immunoglobulin	0.005	0.995	0.000
Y48.5 Therapeutic gases	0.005	0.995	0.000
Y48.1 Parenteral anaesthetics	0.005	0.995	0.000
Y48.0 Inhaled anaesthetics	0.005	0.995	0.000
Y48.3 Local anaesthetics	0.005	0.995	0.000
Y52 Agents primarily affecting the cardiovascular system	0.005	0.995	0.000
Y48.4 Anaesthetic, unspecified	0.004	0.995	0.000
H18.7 Other corneal deformities	0.004	0.996	0.000
H18.3 Changes in corneal membranes	0.004	0.996	0.000
Y57.6 Other diagnostic agents	0.004	0.996	0.000
H18.0 Corneal pigmentations and deposits	0.004	0.996	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.004	0.996	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.004	0.996	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.004	0.996	0.000
Y47.4 Bromine compounds	0.004	0.996	0.000
Y47.3 Paraldehyde	0.004	0.996	0.000
Y47.2 Chloral derivatives	0.004	0.996	0.000
Y47.0 Barbiturates, not elsewhere classified	0.004	0.996	0.000
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.004	0.996	0.000
Z74.0 Reduced mobility	0.004	0.996	0.000
Z99.3 Dependence on wheelchair	0.004	0.996	0.000
H18.4 Corneal degeneration	0.004	0.996	0.000
H20.9 Iridocyclitis, unspecified	0.004	0.996	0.000
Z99.9 Dependence on unspecified enabling machine and device	0.004	0.996	0.000
Z99.4 Dependence on artificial heart	0.004	0.996	0.000
Z99.0 Dependence on aspirator	0.004	0.996	0.000
H18.8 Other specified disorders of cornea	0.004	0.996	0.000
Z74 Problems related to care-provider dependency	0.004	0.996	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.004	0.996	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.004	0.996	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.004	0.996	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.004	0.996	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.004	0.996	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.004	0.996	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.004	0.996	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.004	0.996	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.004	0.996	0.000
Y51.0 Anticholinesterase agents	0.004	0.996	0.000
Y57.8 Other drugs and medicaments	0.004	0.996	0.000
H16 Keratitis	0.004	0.996	0.000
K35.0 Acute appendicitis with generalised peritonitis	0.000	0.996	0.004
K90.9 Intestinal malabsorption, unspecified	0.004	0.996	0.000
Y84 Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure	0.004	0.996	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.004	0.996	0.000
Z74.1 Need for assistance with personal care	0.004	0.996	0.000
Y57.7 Vitamins, not elsewhere classified	0.004	0.996	0.000
Y57.4 Pharmaceutical excipients	0.004	0.996	0.000
Y57.3 Alcohol deterrents	0.004	0.996	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.004	0.996	0.000
Y57.1 Lipotropic drugs	0.004	0.996	0.000
Y57.0 Appetite depressants [anorectics]	0.004	0.996	0.000
Z11.2 Special screening examination for other bacterial diseases	0.004	0.996	0.000
Z74.2 Need for assistance at home and no other household member able to render care	0.004	0.996	0.000
H20 Iridocyclitis	0.004	0.996	0.000
I61.0 Intracerebral haemorrhage in hemisphere, subcortical	0.004	0.996	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.004	0.996	0.000
Y44.7 Plasma substitutes	0.004	0.996	0.000
Y44.6 Natural blood and blood products	0.004	0.996	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.004	0.996	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.004	0.996	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.004	0.996	0.000
B07 Viral warts	0.004	0.996	0.000
K90 Intestinal malabsorption	0.004	0.996	0.000
H22 Disorders of iris and ciliary body in diseases classified elsewhere	0.004	0.996	0.000
Z74.8 Other problems related to care-provider dependency	0.004	0.996	0.000
K92.9 Disease of digestive system, unspecified	0.004	0.996	0.000
Z74.9 Problem related to care-provider dependency, unspecified	0.004	0.996	0.000
H17 Corneal scars and opacities	0.004	0.996	0.000
H18.2 Other corneal oedema	0.003	0.996	0.000
H18.1 Bullous keratopathy	0.003	0.996	0.000
Y45.0 Opioids and related analgesics	0.004	0.996	0.000
K35.9 Acute appendicitis, unspecified	0.000	0.996	0.004
I61.2 Intracerebral haemorrhage in hemisphere, unspecified	0.004	0.996	0.000
Y47.1 Benzodiazepines	0.003	0.996	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.996	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.003	0.996	0.000
Y52.7 Peripheral vasodilators	0.003	0.996	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.003	0.996	0.000
H16.3 Interstitial and deep keratitis	0.003	0.996	0.000
H19 Disorders of sclera and cornea in diseases classified elsewhere	0.003	0.996	0.000
H16.1 Other superficial keratitis without conjunctivitis	0.003	0.996	0.000
H17.8 Other corneal scars and opacities	0.003	0.996	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.996	0.000
I61 Intracerebral haemorrhage	0.004	0.996	0.000
H20.1 Chronic iridocyclitis	0.003	0.996	0.000
K35 Acute appendicitis	0.000	0.996	0.004
H16.0 Corneal ulcer	0.003	0.997	0.000
Y84.2 Radiological procedure and radiotherapy	0.003	0.997	0.000
Y44.5 Thrombolytic drugs	0.003	0.997	0.000
Z51.0 Radiotherapy session	0.003	0.997	0.000
H22.1 Iridocyclitis in other diseases classified elsewhere	0.003	0.997	0.000
K35.3 Acute appendicitis with localized peritonitis	0.000	0.997	0.003
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.003	0.997	0.000
I61.9 Intracerebral haemorrhage, unspecified	0.003	0.997	0.000
M47.86 Other spondylosis (Lumbar region)	0.003	0.997	0.000
Z74.3 Need for continuous supervision	0.003	0.997	0.000
H92 Otalgia and effusion of ear	0.003	0.997	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.003	0.997	0.000
B02.9 Zoster without complication	0.003	0.997	0.000
H15 Disorders of sclera	0.003	0.997	0.000
Y57.9 Drug or medicament, unspecified	0.003	0.997	0.000
H16.4 Corneal neovascularisation	0.003	0.997	0.000
Y84.9 Medical procedure, unspecified	0.003	0.997	0.000
Y84.7 Blood-sampling	0.003	0.997	0.000
Y84.5 Insertion of gastric or duodenal sound	0.003	0.997	0.000
Y84.3 Shock therapy	0.003	0.997	0.000
K35.2 Acute appendicitis with generalized peritonitis	0.000	0.997	0.003
H19.3 Keratitis and keratoconjunctivitis in other diseases classified elsewhere	0.003	0.997	0.000
I61.1 Intracerebral haemorrhage in hemisphere, cortical	0.003	0.997	0.000
H16.8 Other keratitis	0.003	0.997	0.000
H20.2 Lens-induced iridocyclitis	0.003	0.997	0.000
I61.5 Intracerebral haemorrhage, intraventricular	0.003	0.997	0.000
K90.4 Malabsorption due to intolerance, not elsewhere classified	0.003	0.997	0.000
K90.3 Pancreatic steatorrhoea	0.003	0.997	0.000
K90.2 Blind loop syndrome, not elsewhere classified	0.003	0.997	0.000
K90.1 Tropical sprue	0.003	0.997	0.000
H22.8 Other disorders of iris and ciliary body in diseases classified elsewhere	0.003	0.997	0.000
H22.0 Iridocyclitis in infectious and parasitic diseases classified elsewhere	0.003	0.997	0.000
H16.2 Keratoconjunctivitis	0.003	0.997	0.000
M47.8 Other spondylosis	0.003	0.997	0.000
H16.9 Keratitis, unspecified	0.003	0.997	0.000
H17.1 Other central corneal opacity	0.003	0.997	0.000
H17.0 Adherent leukoma	0.003	0.997	0.000
H92.1 Otorrhoea	0.003	0.997	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.003	0.997	0.000
C91.1 Chronic lymphocytic leukaemia	0.003	0.997	0.000
I82.9 Embolism and thrombosis of unspecified vein	0.003	0.997	0.000
B00-B09 Viral infections characterized by skin and mucous membrane lesions	0.003	0.997	0.000
B00.9 Herpesviral infection, unspecified	0.003	0.997	0.000
I61.4 Intracerebral haemorrhage in cerebellum	0.003	0.997	0.000
H19.8 Other disorders of sclera and cornea in diseases classified elsewhere	0.003	0.997	0.000
H19.2 Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere	0.003	0.997	0.000
H19.0 Scleritis and episcleritis in diseases classified elsewhere	0.003	0.997	0.000
I08.0 Disorders of both mitral and aortic valves	0.003	0.997	0.000
B02 Zoster [herpes zoster]	0.003	0.997	0.000
Y84.6 Urinary catheterisation	0.003	0.997	0.000
I61.6 Intracerebral haemorrhage, multiple localised	0.003	0.997	0.000
K90.8 Other intestinal malabsorption	0.003	0.997	0.000
H92.2 Otorrhagia	0.003	0.997	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.003	0.997	0.000
Y84.1 Kidney dialysis	0.003	0.997	0.000
B00 Herpesviral [herpes simplex] infections	0.003	0.997	0.000
H21 Other disorders of iris and ciliary body	0.003	0.997	0.000
S20 Superficial injury of thorax	0.000	0.997	0.003
M89.86 Other specified disorders of bone (Lower leg)	0.003	0.997	0.000
Y44.2 Anticoagulants	0.003	0.997	0.000
O64.0 Obstructed labour due to incomplete rotation of foetal head	0.000	0.997	0.003
I61.8 Other intracerebral haemorrhage	0.003	0.997	0.000
L85.8 Other specified epidermal thickening	0.003	0.997	0.000
M47.80 Other spondylosis (Multiple sites in spine)	0.003	0.997	0.000
H19.1 Herpesviral keratitis and keratoconjunctivitis	0.002	0.997	0.000
M89.88 Other specified disorders of bone (Other)	0.003	0.997	0.000
K35.1 Acute appendicitis with peritoneal abscess	0.000	0.997	0.003
C10.9 Oropharynx, unspecified	0.003	0.997	0.000
H15.0 Scleritis	0.002	0.997	0.000
M89.8 Other specified disorders of bone	0.003	0.997	0.000
B00.2 Herpesviral gingivostomatitis and pharyngotonsillitis	0.002	0.997	0.000
H15.9 Disorder of sclera, unspecified	0.002	0.997	0.000
Y43 Primarily systemic agents	0.003	0.997	0.000
M89.81 Other specified disorders of bone (Shoulder region)	0.002	0.997	0.000
Y76.2 Prosthetic and other implants, materials and accessory devices	0.002	0.997	0.000
B01 Varicella [chickenpox]	0.002	0.997	0.000
M47.83 Other spondylosis (Cervicothoracic region)	0.002	0.997	0.000
H17.9 Corneal scar and opacity, unspecified	0.002	0.997	0.000
Y57.5 X-ray contrast media	0.002	0.997	0.000
B02.8 Zoster with other complications	0.002	0.997	0.000
H20.8 Other iridocyclitis	0.002	0.997	0.000
H15.8 Other disorders of sclera	0.002	0.998	0.000
Y84.0 Cardiac catheterisation	0.002	0.998	0.000
N05.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
S79.9 Unspecified injury of hip and thigh	0.002	0.998	0.000
C16.9 Stomach, unspecified	0.002	0.998	0.000
N05.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
Y52.1 Calcium-channel blockers	0.002	0.998	0.000
M47.88 Other spondylosis (Sacral and sacrococcygeal region)	0.002	0.998	0.000
I61.3 Intracerebral haemorrhage in brain stem	0.002	0.998	0.000
M47.85 Other spondylosis (Thoracolumbar region)	0.002	0.998	0.000
M47.81 Other spondylosis (Occipito-atlanto-axial region)	0.002	0.998	0.000
H15.1 Episcleritis	0.002	0.998	0.000
N04.9 Unspecified	0.002	0.998	0.000
Y84.4 Aspiration of fluid	0.002	0.998	0.000
H21.5 Other adhesions and disruptions of iris and ciliary body	0.002	0.998	0.000
S20.3 Other superficial injuries of front wall of thorax	0.000	0.998	0.002
Z49.0 Preparatory care for dialysis	0.002	0.998	0.000
V18.2 Unspecified pedal cyclist injured in nontraffic accident	0.002	0.998	0.000
B06 Rubella [German measles]	0.002	0.998	0.000
B05 Measles	0.002	0.998	0.000
B09 Unspecified viral infection characterised by skin and mucous membrane lesions	0.002	0.998	0.000
B04 Monkeypox	0.002	0.998	0.000
B03 Smallpox	0.002	0.998	0.000
B01.8 Varicella with other complications	0.002	0.998	0.000
H21.2 Degeneration of iris and ciliary body	0.002	0.998	0.000
B02.7 Disseminated zoster	0.002	0.998	0.000
B02.1 Zoster meningitis	0.002	0.998	0.000
B02.0 Zoster encephalitis	0.002	0.998	0.000
M89.85 Other specified disorders of bone (Pelvic region and thigh)	0.002	0.998	0.000
S20.1 Other and unspecified superficial injuries of breast	0.000	0.998	0.002
Y76 Obstetric and gynaecological devices associated with adverse incidents	0.002	0.998	0.000
S20.2 Contusion of thorax	0.000	0.998	0.002
S20.7 Multiple superficial injuries of thorax	0.000	0.998	0.002
S20.0 Contusion of breast	0.000	0.998	0.002
Y43.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
B00.8 Other forms of herpesviral infection	0.002	0.998	0.000
B00.7 Disseminated herpesviral disease	0.002	0.998	0.000
B00.3 Herpesviral meningitis	0.002	0.998	0.000
B00.0 Eczema herpeticum	0.002	0.998	0.000
H21.4 Pupillary membranes	0.002	0.998	0.000
H21.3 Cyst of iris, ciliary body and anterior chamber	0.002	0.998	0.000
C07 Malignant neoplasm of parotid gland	0.002	0.998	0.000
M47.84 Other spondylosis (Thoracic region)	0.002	0.998	0.000
B00.1 Herpesviral vesicular dermatitis	0.002	0.998	0.000
C77.4 Inguinal and lower limb lymph nodes	0.000	0.998	0.002
H21.9 Disorder of iris and ciliary body, unspecified	0.002	0.998	0.000
J11.1 Influenza with other respiratory manifestations, virus not identified	0.002	0.998	0.000
M89.89 Other specified disorders of bone (Site unspecified)	0.002	0.998	0.000
M89.87 Other specified disorders of bone (Ankle and foot)	0.002	0.998	0.000
M89.84 Other specified disorders of bone (Hand)	0.002	0.998	0.000
M89.83 Other specified disorders of bone (Forearm)	0.002	0.998	0.000
M89.82 Other specified disorders of bone (Upper arm)	0.002	0.998	0.000
M89.80 Other specified disorders of bone (Multiple sites)	0.002	0.998	0.000
Y79.2 Prosthetic and other implants, materials and accessory devices	0.002	0.998	0.000
M23.36 Other meniscus derangements (Other and unspecified lateral meniscus)	0.002	0.998	0.000
Y43.9 Primarily systemic agent, unspecified	0.002	0.998	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.002	0.998	0.000
Y43.6 Enzymes, not elsewhere classified	0.002	0.998	0.000
Y43.5 Acidifying and alkalising agents	0.002	0.998	0.000
Y43.2 Antineoplastic natural products	0.002	0.998	0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.002	0.998	0.000
B01.2 Varicella pneumonia	0.002	0.998	0.000
B01.1 Varicella encephalitis	0.002	0.998	0.000
B01.0 Varicella meningitis	0.002	0.998	0.000
V14.4 Driver injured in traffic accident	0.002	0.998	0.000
Y79 Orthopaedic devices associated with adverse incidents	0.002	0.998	0.000
V10-V19 Pedal cyclist injured in transport accident	0.002	0.998	0.000
B01.9 Varicella without complications	0.002	0.998	0.000
B02.2 Zoster with other nervous system involvement	0.002	0.998	0.000
V14 Pedal cyclist injured in collision with heavy transport vehicle or bus	0.002	0.998	0.000
B00.5 Herpesviral ocular disease	0.002	0.998	0.000
H21.1 Other vascular disorders of iris and ciliary body	0.002	0.998	0.000
H21.0 Hyphaema	0.002	0.998	0.000
C10 Malignant neoplasm of oropharynx	0.002	0.998	0.000
N05 Unspecified nephritic syndrome	0.002	0.998	0.000
H20.0 Acute and subacute iridocyclitis	0.001	0.998	0.001
Z87.0 Personal history of diseases of the respiratory system	0.002	0.998	0.000
B08 Other viral infections characterised by skin and mucous membrane lesions, not elsewhere classified	0.002	0.998	0.000
N04 Nephrotic syndrome	0.002	0.998	0.000
D63.0 Anaemia in neoplastic disease	0.002	0.998	0.000
H72.0 Central perforation of tympanic membrane	0.000	0.998	0.002
S20.4 Other superficial injuries of back wall of thorax	0.000	0.998	0.002
Y71 Cardiovascular devices associated with adverse incidents	0.002	0.998	0.000
M75.9 Shoulder lesion, unspecified	0.002	0.998	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.998	0.002
Y43.1 Antineoplastic antimetabolites	0.002	0.998	0.000
V19 Pedal cyclist injured in other and unspecified transport accidents	0.002	0.998	0.000
B05.9 Measles without complication	0.002	0.998	0.000
B05.8 Measles with other complications	0.002	0.998	0.000
B05.4 Measles with intestinal complications	0.002	0.998	0.000
B05.3 Measles complicated by otitis media	0.002	0.998	0.000
B05.2 Measles complicated by pneumonia	0.002	0.998	0.000
B05.1 Measles complicated by meningitis	0.002	0.998	0.000
B05.0 Measles complicated by encephalitis	0.002	0.998	0.000
B06.9 Rubella without complication	0.002	0.998	0.000
B06.8 Rubella with other complications	0.002	0.998	0.000
B06.0 Rubella with neurological complications	0.002	0.998	0.000
J11.0 Influenza with pneumonia, virus not identified	0.002	0.998	0.000
N04.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
Y71.1 Therapeutic (nonsurgical) and rehabilitative devices	0.002	0.998	0.000
V18 Pedal cyclist injured in noncollision transport accident	0.002	0.998	0.000
V17 Pedal cyclist injured in collision with fixed or stationary object	0.002	0.998	0.000
Y76.8 Miscellaneous devices, not elsewhere classified	0.002	0.998	0.000
Y76.3 Surgical instruments, materials and devices (including sutures)	0.002	0.998	0.000
Y76.1 Therapeutic (nonsurgical) and rehabilitative devices	0.002	0.998	0.000
Y76.0 Diagnostic and monitoring devices	0.002	0.998	0.000
B00.4 Herpesviral encephalitis	0.002	0.998	0.000
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified	0.002	0.998	0.000
V19.3 Pedal cyclist [any] injured in an unspecified nontraffic accident	0.002	0.998	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.001	0.998	0.001
K35.8 Acute appendicitis, other and unspecified	0.000	0.998	0.002
T93.0 Sequelae of open wound of lower limb	0.002	0.998	0.000
S42.10 Fracture of scapula (closed)	0.002	0.998	0.000
B02.3 Zoster ocular disease	0.002	0.998	0.000
D48.6 Breast	0.002	0.998	0.000
Y82 Other and unspecified medical devices associated with adverse incidents	0.002	0.998	0.000
Z11 Special screening examination for infectious and parasitic diseases	0.002	0.998	0.000
V17.0 Driver injured in nontraffic accident	0.002	0.998	0.000
V18.1 Passenger injured in nontraffic accident	0.002	0.998	0.000
M79.09 Rheumatism, unspecified (Site unspecified)	0.002	0.998	0.000
E85.9 Amyloidosis, unspecified	0.002	0.998	0.000
H21.8 Other specified disorders of iris and ciliary body	0.002	0.998	0.000
Y81 General- and plastic-surgery devices associated with adverse incidents	0.002	0.998	0.000
Y80 Physical medicine devices associated with adverse incidents	0.002	0.998	0.000
Y78 Radiological devices associated with adverse incidents	0.002	0.998	0.000
Y75 Neurological devices associated with adverse incidents	0.002	0.998	0.000
Y74 General hospital and personal-use devices associated with adverse incidents	0.002	0.998	0.000
Y73 Gastro-enterology and urology devices associated with adverse incidents	0.002	0.998	0.000
Y72 Otorhinolaryngological devices associated with adverse incidents	0.002	0.998	0.000
Y70 Anaesthesiology devices associated with adverse incidents	0.002	0.998	0.000
S42.70 Multiple fractures of clavicle, scapula and humerus (closed)	0.002	0.998	0.000
Y83-Y84 Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure	0.002	0.998	0.000
V14.9 Unspecified pedal cyclist injured in traffic accident	0.002	0.998	0.000
V14.5 Passenger injured in traffic accident	0.002	0.998	0.000
V14.3 Person injured while boarding or alighting	0.002	0.998	0.000
V14.2 Unspecified pedal cyclist injured in nontraffic accident	0.002	0.998	0.000
V14.1 Passenger injured in nontraffic accident	0.002	0.998	0.000
V14.0 Driver injured in nontraffic accident	0.002	0.998	0.000
Y79.8 Miscellaneous devices, not elsewhere classified	0.002	0.998	0.000
Y79.1 Therapeutic (nonsurgical) and rehabilitative devices	0.002	0.998	0.000
Y79.0 Diagnostic and monitoring devices	0.002	0.998	0.000
V16 Pedal cyclist injured in collision with other nonmotor vehicle	0.002	0.998	0.000
V15 Pedal cyclist injured in collision with railway train or railway vehicle	0.002	0.998	0.000
V13 Pedal cyclist injured in collision with car, pick-up truck or van	0.002	0.998	0.000
V12 Pedal cyclist injured in collision with two- or three-wheeled motor vehicle	0.002	0.998	0.000
V11 Pedal cyclist injured in collision with other pedal cycle	0.002	0.998	0.000
V10 Pedal cyclist injured in collision with pedestrian or animal	0.002	0.998	0.000
B08.8 Other specified viral infections characterised by skin and mucous membrane lesions	0.001	0.998	0.000
B08.5 Enteroviral vesicular pharyngitis	0.001	0.998	0.000
B08.4 Enteroviral vesicular stomatitis with exanthem	0.001	0.998	0.000
B08.3 Erythema infectiosum [fifth disease]	0.001	0.998	0.000
B08.2 Exanthema subitum [sixth disease]	0.001	0.998	0.000
B08.0 Other orthopoxvirus infections	0.001	0.998	0.000
C10.8 Overlapping lesion of oropharynx	0.002	0.998	0.000
C10.4 Branchial cleft	0.002	0.998	0.000
C10.3 Posterior wall of oropharynx	0.002	0.998	0.000
C10.2 Lateral wall of oropharynx	0.002	0.998	0.000
C10.1 Anterior surface of epiglottis	0.002	0.998	0.000
C10.0 Vallecula	0.002	0.998	0.000
N04.8 Other	0.002	0.998	0.000
N04.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
N04.6 Dense deposit disease	0.002	0.998	0.000
N04.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
N04.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N04.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
N04.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
N04.0 Minor glomerular abnormality	0.002	0.998	0.000
N05.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
N05.6 Dense deposit disease	0.002	0.998	0.000
N05.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N05.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
N05.0 Minor glomerular abnormality	0.002	0.998	0.000
S60.9 Superficial injury of wrist and hand, unspecified	0.000	0.998	0.002
I42.9 Cardiomyopathy, unspecified	0.000	0.998	0.002
T84.9 Unspecified complication of internal orthopaedic prosthetic device, implant and graft	0.002	0.998	0.000
V19.4 Driver injured in collision with other and unspecified motor vehicles in traffic accident	0.002	0.998	0.000
Y71.8 Miscellaneous devices, not elsewhere classified	0.002	0.998	0.000
Y71.3 Surgical instruments, materials and devices (including sutures)	0.002	0.998	0.000
Y71.2 Prosthetic and other implants, materials and accessory devices	0.002	0.998	0.000
Y71.0 Diagnostic and monitoring devices	0.002	0.998	0.000
C34.1 Upper lobe, bronchus or lung	0.000	0.998	0.002
V17.4 Driver injured in traffic accident	0.002	0.998	0.000
V19.9 Pedal cyclist [any] injured in unspecified traffic accident	0.002	0.998	0.000
V19.6 Unspecified pedal cyclist injured in collision with other and unspecified motor vehicles in traffic accident	0.002	0.998	0.000
V19.2 Unspecified pedal cyclist injured in collision with other and unspecified motor vehicles in nontraffic accident	0.002	0.998	0.000
V19.5 Passenger injured in collision with other and unspecified motor vehicles in traffic accident	0.002	0.998	0.000
V19.1 Passenger injured in collision with other and unspecified motor vehicles in nontraffic accident	0.002	0.998	0.000
V19.0 Driver injured in collision with other and unspecified motor vehicles in nontraffic accident	0.002	0.998	0.000
Y79.3 Surgical instruments, materials and devices (including sutures)	0.002	0.998	0.000
Y77 Ophthalmic devices associated with adverse incidents	0.002	0.998	0.000
I05.1 Rheumatic mitral insufficiency	0.002	0.998	0.000
V19.8 Pedal cyclist [any] injured in other specified transport accidents	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations